Dr. Kelly has authored over 220 peer-reviewed publications published in prominent scientific journals including Science, Nature, Cell, New England Journal of Medicine, Proceedings of the National Academy of Sciences, Journal of the American Chemical Society, Biochemistry, and Journal of Medicinal Chemistry. For reprint requests, please click here.
2000:
- Kelly JW. Mechanisms of amyloidogenesis. Nat. Struct. Biol. 2000;7:824-826.
- Liu K, Cho HS, Hoyt DW, Nguyen TN, Olds P, Kelly JW, Wemmer DE. Deuterium-proton exchange on the native wild-type transthyretin tetramer identifies the stable core of the individual subunits and indicates mobility at the subunit interface. J. Mol. Biol. 2000;303:555-565.
- Raman P, Razavi H, Kelly JW. Titanium(IV)-mediated tandem deprotection-cyclodehydration of protected cysteine N-amides: biomimetic syntheses of thiazoline- and thiazole-containing heterocycles. Org. Lett. 2000;2:3289-3292.
- Liu K, Cho HS, Lashuel HA, Kelly JW, Wemmer DE. A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat. Struc. Biol. 2000;7:754-757.
- Lashuel HA, LaBrenz SR, Woo L, Serpell LC, Kelly JW. Protofilaments, filaments, ribbons, and fibrils from peptidomimetic self-assembly: implications for amyloid fibril formation and materials science. J. Am. Chem. Soc. 2000;122:5262-5277.
- Crane JC, Koepf EK, Kelly JW, Gruebele M. Mapping the transition state of the WW domain β-sheet. J. Mol. Biol. 2000;298:283-292.
- Petrassi HM, Klabunde T, Sacchettini J, Kelly JW. Structure-based design of N-phenyl phenoxazine transthyretin amyloid fibril inhibitors. J. Am. Chem. Soc. 2000;122:2178-2192.
- Klabunde T, Petrassi HM, Oza VB, Raman P, Kelly JW, Sacchettini JC. Rational design of potent human transthyretin amyloid disease inhibitors. Nat. Struct. Biol. 2000;7:312-321.
